News
12-14-2012, 01:31 AM
A novel approach to identifying potential anticancer drug combinations revealed that pairing cholesterol-reducing drugs called statins with cyclin-dependent kinase inhibitors might provide an effective approach to treating intractable melanomas driven by mutations in the NRAS and KRAS gene.
More... (http://www.news-medical.net/news/20121214/Pairing-statins-with-cyclin-dependent-kinase-inhibitors-might-effectively-treat-melanomas.aspx)
More... (http://www.news-medical.net/news/20121214/Pairing-statins-with-cyclin-dependent-kinase-inhibitors-might-effectively-treat-melanomas.aspx)